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Emerging Infections and Disease
Emergence
To the Editor: Emerging infections have been
defined as diseases whose incidence in humans
has increased within the last 2 decades or
threatens to increase in the near future (l). This
definition, with minor variations, has continued
to be used, although occasional debate erupts
over whether one disease or another is truly
emerging. Use of the term emerging has
facilitated communication about the changed
pattern of infectious diseases in recent years.
While the study of infectious organisms and
clinical training about emerging infections are
manifestly necessary, they are not a sufficient
foundation for understanding the process of
disease emergence. I would propose, specifically,
that we distinguish between emerging dis-
easesthe study of specific infections that are
changingand the study of disease emergence.
Studies of emerging infections typically rely
on disease, organismic, or syndromic ap-
proaches. Meetings on emerging infections
typically cover newly recognized or character-
ized organisms or diseases and update informa-
tion about the recognition, diagnosis, treatment,
prevention, and control of these infections. This
ongoing education is essential for practicing
clinicians, who finished their formal training
before AIDS, Lyme disease, ehrlichiosis,
Helicobacter pylori infection, cryptosporidiosis,
cyclosporiasis, and many other infections were
described. These meetings also help clinicians
learn how to fit new information into their existing
knowledge base: What is the probability that a
person with rash and fever has ehrlichiosis and
that a person with fever and pulmonary
infiltrates has hantavirus pulmonary syndrome?
By contrast, understanding the process of
disease emergence involves studying the origins
and ecology of emerging infections. Many
disciplines relevant to disease emergence lie
outside traditional infectious disease training
and research and include evolutionary biology,
demography, population dynamics, ecology,
vector biology, climatology, epidemiology, genet-
ics, veterinary medicine, and behavioral sciences
(2). Infectious diseases of animals and plants
have both a direct and indirect impact on human
health. The study of infectious diseases in other
species may provide important insights into
understanding the process of disease emergence
in humans. The study is also relevant to
understanding the species-to-species spread of
organisms.
Tools used to study and understand disease
emergence include mathematical modeling,
geographic information systems, remote sens-
ing, molecular methods to study the genetic
relatedness of organisms, and molecular phylog-
eny. Paleobiology, paleoecology, and studies that
allow the reconstruction of past events may help
inform future research and policy.
A major challenge is to reach people with
relevant skills, knowledge, and experience and
develop a coherent framework to advance the
understanding of the process of disease
emergence. No one institution, organization, or
country can itself prevent or manage emerging
infectious diseases.
In the study of emerging infections we focus
on the organism, the patient, and the human
population. The study of disease emergence must
be at the systems level and must look at
ecosystems, evolutionary biology, and popula-
tions of parasites and hosts, whatever their
species. A primary goal should be to identify
conditions or combinations or sequences of
events that herald a changed pattern of infections
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Malaria Control in South America
To the Editor: The article by Roberts et al.
regarding DDT use and malaria in South
America (1) correctly observes that health policy
makers have shifted the emphasis of malaria
control programs from vector control to case
detection and treatment and that malaria
control has been woefully underfunded in recent
years. However, their conclusions that increased
malaria is due to decreased spraying of homes
with DDT and that DDT is still needed for
malaria control do not withstand close scrutiny.
The authors did not mention several factors
influencing malaria increase in recent decades,
including growing antimalarial-drug resistance,
the deterioration of public health systems
responsible for malaria control, and large-scale
migration to areas at high risk for malaria (e.g.,
almost all Brazilian malaria cases occur in the
Amazon region) (2,3). Extradomiciliary malaria
transmission, poor housing conditions, and
human behavior in frontier areas such as the
Amazon region limit the usefulness of insecti-
cides. Thus, the deduction of causality between
less house spraying with DDT and increased
malaria incidence under those circumstances is
questionable.
Roberts et al. have not actually linked
increased malaria with eliminating DDT use but
rather with eliminating house spraying alto-
gether, without implementing effective alterna-
tives. Malarias recent decline in Brazil is due to
a strategy that combines health education,
aggressive case detection and treatment, and
environmental management to eliminate Anoph-
eles breeding sites (C. Catão Prates, unpub.
data). A similar strategy has sharply reduced
malaria incidence and deaths in Colombia (W.
Rojas, unpub. data). In Mexico, use of two
synthetic pyrethroid insecticides (deltamethrin
and lambda cyhalothrin) for bed-net treatment
and house spraying is controlling malaria at a
much lower cost than the use of the alternative
insecticides tried earlier and mentioned by
Roberts et al. (4). Far from being pursued
without meaningful debate, the reduction and
phaseout of DDT and other persistent organic
pollutants is the subject of a 3-year United
Nationsfacilitated global negotiation process
begun in June 1998.
Roberts et al. assert that DDT applied
indoors does not move easily from the application
site; however, a mass balance model indicates
that 60% to 80% of the DDT ends up outdoors
within 6 months (K. Feltmate, A model and
assessment of the fate and exposure of DDT
following indoor application [bachelors thesis].
Ontario: Trent University; 1998). From there,
DDT can be transported long distances in air,
waterborne sediments, and biota, accumulating
in humans and other nontarget species (5).
Meanwhile, residents of sprayed houses accumu-
late high, persistent body levels of DDT through
skin contact and food contaminated with DDT
from air and dust (6).
Long considered a probable human carcino-
gen, DDT also is associated with reduced
lactation, premature births, absorbed fetuses,
and lower birth weights (7-9). In addition, recent
animal research has raised the possibility that
exposure of human fetuses or infants to DDT
may cause permanent behavioral changes and
impairment of body systems (10-12).
Synthetic pyrethroid insecticides used on
bed nets or for house spraying against malaria-
infected mosquitoes seem safer for human health
than DDT because humans and other mammals
possess the ability to hydrolyze the pyrethroids
rapidly and excrete them from the body (13-14).
Nevertheless, DDT and pyrethroids share
known health risks, notably endocrine disrup-
tion, and the possible transgenerational conse-
quences of chronic human exposure to pyrethroids
have not yet been studied (10,15-16). Optimal
protection of human health requires the develop-
ment of integrated malaria control strategies
that eliminate or reduce routine insecticide use
by taking maximum advantage of environmental
management, biological controls, and other
nonchemical vector control measures (17).